Related Experiment Videos
High-throughput analysis of informative CYP2D6 compound haplotypes.
Benjamin Fletcher1, David B Goldstein, Amanda L R Bradman
1The Centre for Genetic Anthropology, Department of Biology and Department of Anthropology, University College London, UK.
Genomics
|March 7, 2003
Summary
This study presents a fast, cost-effective method using GeneScan technology to identify drug-metabolizing enzyme CYP2D6 gene variations and linked microsatellites, aiding genetic research.
Area of Science:
- Pharmacogenomics
- Molecular Genetics
- Biotechnology
Background:
- The drug-metabolizing enzyme CYP2D6 exhibits significant genetic polymorphism, impacting drug efficacy and safety.
- Accurate and efficient genotyping of CYP2D6 alleles and linked markers is crucial for pharmacogenetic studies.
Purpose of the Study:
- To develop and validate a high-throughput, cost-effective protocol for detecting common CYP2D6 polymorphisms and linked microsatellites.
- To facilitate rapid allele discrimination, high-resolution haplotyping, and compound haplotype generation for CYP2D6 variation studies.
Main Methods:
- Utilized GeneScan technology for high-throughput analysis.
- Employed three Polymerase Chain Reactions (PCRs) and two GeneScan runs per sample.
- Assayed seven single nucleotide polymorphisms (SNPs) in CYP2D6 and five dinucleotide microsatellite loci.
Main Results:
- Developed a rapid and inexpensive protocol for CYP2D6 genotyping and microsatellite analysis.
- Enabled efficient discrimination of common CYP2D6 alleles and high-resolution haplotyping.
- Reported compound haplotype frequencies in Ashkenazi Jewish and British populations.
Conclusions:
- The described method offers a valuable tool for researchers studying CYP2D6 variation, pharmacogenetics, and human population genetics.
- This approach supports association studies and investigations into the evolution of CYP2D6 genetic diversity.
- The protocol's efficiency and cost-effectiveness make it suitable for large-scale genetic analyses.